Case Study: a global pharmaceutical company strengthens T&E compliance and reduces risk with Oversight

Global Pharmaceutical Company uncovers $8.8M in non-compliant spend with Oversight

A global pharmaceutical company faced significant challenges in managing travel and expense (T&E) compliance across its complex, high-volume operations. Despite existing audit processes, the company struggled to identify non-compliant and duplicate expenses, faced compliance exposure in high-risk regions, was burdened by manual reviews, and lacked clear visibility into risk. To address this, they partnered with Oversight for its continuous monitoring and analytics solution.

Oversight implemented a centralized control layer to continuously analyze T&E and corporate card transactions. Their solution used pattern-based risk detection to identify systemic issues and automated targeted employee communications to correct behavior. The results were substantial, including the identification of $8.8 million in non-compliant spend and $203,000 in duplicate expenses, with $205,000 total reimbursed to the company. Critically, Oversight helped drive a 36% reduction in findings among employees who received their communications, proving a measurable improvement in compliance behavior and audit efficiency.